Similarly, as illustrated in Figure 3C, the expression of FOS, PTGS2, SOCS3, ZFP36, and BTG2 was higher in the AF group, NAFLD group, and NAFLD-AF group compared to the HC group, whereas PTGS2 expression was notably lower in the NAFLD-AF group. This evidence concerns the gene FOS and metabolic dysfunction-associated steatotic liver disease.